Marker Identifies Breast Cancer Patients Likely To Respond To Tamoxifen

[News]

Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy. The research appears in the May 16 online issue of the Journal of Clinical Oncology...

More... (http://www.medicalnewstoday.com/releases/225782.php)